For more information, visit www.miltenyibiotec.com/DE-en/... Natural killer (NK) cells are cytotoxic innate lymphocytes capable of direct recognition and the elimination of viral-infected or malignant cells.
In this webinar, we will address how to efficiently manufacture gene-engineered NK cells for clinical applications using an automated and closed system.
Furthermore, we will look into options to upscale NK cell manufacturing and how to standardize the in-process control (IPC) and quality control (QC) steps associated with the process.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.